PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Health Policy research center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. moghadami@sums.ac.ir.\', \'Health Policy research center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Non-communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Ali Asghar hospital, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Shiraz Geriatric Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12879-021-06045-3
?:doi
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33838657
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
?:title
  • Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all